Spatial variation of perfusion MRI reflects cognitive decline in mild cognitive impairment and early dementia

Catherine A Morgan1,2,3, Tracy R Melzer4,5,6,7, Reece P Roberts8,4

  • 1School of Psychology and Centre for Brain Research, The University of Auckland, Building 302, Level 2, 23 Symonds Street, Private Bag 92019, Auckland, 1142, New Zealand. c.morgan@auckland.ac.nz.

Scientific Reports
|December 3, 2021
PubMed

Insights

The spatial coefficient of variation (sCoV) of cerebral blood flow (CBF) measured by ASL MRI increases with cognitive decline in Alzheimer's disease. This imaging metric suggests impaired vascular health contributes to cognitive impairment.

Area of Science:

  • Neuroimaging
  • Vascular Neurology
  • Cognitive Neuroscience

Background:

  • Cerebral blood flow (CBF) assessed via arterial spin labelling (ASL) MRI indicates brain perfusion and vascular health.
  • Arterial transit time (ATT) is a marker of vascular health, but its direct measurement can be challenging.
  • Spatial coefficient of variation (sCoV) of CBF maps may serve as a surrogate for ATT.

Purpose of the Study:

  • To investigate the utility of sCoV of CBF maps as a surrogate for ATT.
  • To assess sCoV in individuals with subjective cognitive decline (SCD), mild cognitive impairment (MCI), and Alzheimer's dementia (AD).

Main Methods:

  • Whole-brain pseudo continuous ASL MRI was conducted at 3 Tesla.
  • 122 participants (20 controls, 44 SCD, 45 MCI, 13 AD) were recruited across three New Zealand sites.
  • sCoV was calculated from CBF maps, analyzing both whole grey matter and temporal lobe regions.

Main Results:

  • sCoV of CBF progressively increased across groups with increasing cognitive deficit (Controls < SCD < MCI < AD).
  • This trend was consistent when analyzing sCoV in the temporal lobe exclusively.
  • sCoV demonstrated sensitivity to varying degrees of cognitive impairment.

Conclusions:

  • sCoV derived from ASL MRI is a simple, computable metric sensitive to cognitive changes.
  • Increased sCoV suggests impaired cerebrovascular health contributes to cognitive decline in Alzheimer's disease spectrum.
  • This finding supports the role of vascular factors in the pathophysiology of cognitive decline.